Blood DNA methylation markers are associated with diabetic kidney disease progression in type 1 diabetes.

Saved in:
Bibliographic Details
Title: Blood DNA methylation markers are associated with diabetic kidney disease progression in type 1 diabetes.
Authors: Syreeni A; Folkhälsan Research Center, Helsinki, Finland.; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Dahlström EH; Folkhälsan Research Center, Helsinki, Finland.; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Smyth LJ; Molecular Epidemiology Research Group, Centre for Public Health, Queen's University Belfast, Belfast, UK., Hill C; Molecular Epidemiology Research Group, Centre for Public Health, Queen's University Belfast, Belfast, UK., Mutter S; Folkhälsan Research Center, Helsinki, Finland.; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Harjutsalo V; Folkhälsan Research Center, Helsinki, Finland.; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Chen Z; Department of Diabetes Complications and Metabolism, Arthur Riggs Diabetes & Metabolism Research Institute and Beckman Research Institute of City of Hope, Duarte, CA, USA., Natarajan R; Department of Diabetes Complications and Metabolism, Arthur Riggs Diabetes & Metabolism Research Institute and Beckman Research Institute of City of Hope, Duarte, CA, USA., Krolewski AS; Section on Genetics and Epidemiology, Research Division, Joslin Diabetes Center, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Hirschhorn JN; Programs in Metabolism and Medical & Population Genetics, Broad Institute, Cambridge, MA, USA.; Department of Genetics, Harvard Medical School, Boston, MA, USA.; Division of Endocrinology and Center for Basic and Translational Obesity Research, Boston Children's Hospital, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Boston, MA, USA., Florez JC; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Programs in Metabolism and Medical & Population Genetics, Broad Institute, Cambridge, MA, USA.; Center for Genomic Medicine and Diabetes Unit, Endocrine Division, Massachusetts General Hospital, Boston, MA, USA., Maxwell AP; Molecular Epidemiology Research Group, Centre for Public Health, Queen's University Belfast, Belfast, UK., Groop PH; Folkhälsan Research Center, Helsinki, Finland.; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia.; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia., McKnight AJ; Molecular Epidemiology Research Group, Centre for Public Health, Queen's University Belfast, Belfast, UK. a.j.mcknight@qub.ac.uk., Sandholm N; Folkhälsan Research Center, Helsinki, Finland. niina.sandholm@helsinki.fi.; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. niina.sandholm@helsinki.fi.; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland. niina.sandholm@helsinki.fi.
Corporate Authors: GENIE Consortium, FinnDiane Study Group
Source: Diabetologia [Diabetologia] 2026 May; Vol. 69 (5), pp. 1317-1336. Date of Electronic Publication: 2026 Jan 22.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0428 (Electronic) Linking ISSN: 0012186X NLM ISO Abbreviation: Diabetologia Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first